A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 19 02 2021
accepted: 16 04 2021
entrez: 24 5 2021
pubmed: 25 5 2021
medline: 21 12 2021
Statut: epublish

Résumé

There is no universal consensus on the practical implementation and evaluation of the Amsterdam Declaration on Graves Orbitopathy in a Multidisciplinary Thyroid Eye Disease (MDTED) pathway. Recent recommendations from the UK TEAMeD-5 and BOPSS initiative highlight the importance of prevention, screening, and prompt referral of patients with moderate to severe and sight-threatening thyroid eye disease to multidisciplinary (MDTED) clinics and recommends annual auditing. We propose a practical service evaluation model with Key Performance Indicators (KPI) that are achievable and could be implemented across most TED pathways. We conducted a service evaluation from an integrated TED pathway in London with three MDTED clinics. Data was collected retrospectively from consecutive TED patients included: 1) Patient demographics, 2) Referral to first appointment time, 3) Documented smoking cessation and selenium supplementation advice, 4) Presenting disease activity and severity, 5) Investigations and treatments, including radio-iodine, 6) Time from decision to treatment initiation, 7) Initial and subsequent thyroid status. The median age was 49.0 yrs, 77.5% (183/236) were female and 49.5% (101/204) Afro-Caribbean or Asian. At their first clinic attendance, 47.6% (110/231) were biochemically euthyroid and 76.7% (79/103) at discharge. All 23.1% (52/225) current smokers received smoking cessation advice and 64.8% (153/236) received selenium supplementation advice. Intravenous methylprednisolone was given to 33.9% (80/236) patients and 12.7% (30/236) received second-line immunosuppression. All 7.2% (17/236) patients with sight-threatening disease received treatment within two weeks of diagnosis. This study forms a waymark for other units using TEAMeD-5 and BOPSS audit criteria. Dedicated electronic patient records with ongoing data capture, including quality of life assessments, and diagnostic coding would significantly aid future auditing, improve patient care, and facilitate a national audit of TED management. A future survey when the TED standards have become embedded would be instructive to see whether this has improved TED care.

Sections du résumé

Background/Aims
There is no universal consensus on the practical implementation and evaluation of the Amsterdam Declaration on Graves Orbitopathy in a Multidisciplinary Thyroid Eye Disease (MDTED) pathway. Recent recommendations from the UK TEAMeD-5 and BOPSS initiative highlight the importance of prevention, screening, and prompt referral of patients with moderate to severe and sight-threatening thyroid eye disease to multidisciplinary (MDTED) clinics and recommends annual auditing. We propose a practical service evaluation model with Key Performance Indicators (KPI) that are achievable and could be implemented across most TED pathways.
Material and Methods
We conducted a service evaluation from an integrated TED pathway in London with three MDTED clinics. Data was collected retrospectively from consecutive TED patients included: 1) Patient demographics, 2) Referral to first appointment time, 3) Documented smoking cessation and selenium supplementation advice, 4) Presenting disease activity and severity, 5) Investigations and treatments, including radio-iodine, 6) Time from decision to treatment initiation, 7) Initial and subsequent thyroid status.
Results
The median age was 49.0 yrs, 77.5% (183/236) were female and 49.5% (101/204) Afro-Caribbean or Asian. At their first clinic attendance, 47.6% (110/231) were biochemically euthyroid and 76.7% (79/103) at discharge. All 23.1% (52/225) current smokers received smoking cessation advice and 64.8% (153/236) received selenium supplementation advice. Intravenous methylprednisolone was given to 33.9% (80/236) patients and 12.7% (30/236) received second-line immunosuppression. All 7.2% (17/236) patients with sight-threatening disease received treatment within two weeks of diagnosis.
Conclusions
This study forms a waymark for other units using TEAMeD-5 and BOPSS audit criteria. Dedicated electronic patient records with ongoing data capture, including quality of life assessments, and diagnostic coding would significantly aid future auditing, improve patient care, and facilitate a national audit of TED management. A future survey when the TED standards have become embedded would be instructive to see whether this has improved TED care.

Identifiants

pubmed: 34025584
doi: 10.3389/fendo.2021.669871
pmc: PMC8138583
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

669871

Informations de copyright

Copyright © 2021 Farag, Feeney, Lee, Nagendran, Jain, Aziz, Akishar, Bravis and Meeran.

Déclaration de conflit d'intérêts

VL is the British Oculoplastic Surgery Society National Lead for TEAMeD (UK Thyroid Eye Disease Amsterdam Declaration Implementation Group). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Orbit. 2017 Jun;36(3):159-169
pubmed: 28296512
Eur J Endocrinol. 2011 May;164(5):649-55
pubmed: 21367964
Orbit. 2018 Oct;37(5):325-330
pubmed: 29319381
AJNR Am J Neuroradiol. 2020 Aug;41(8):1466-1472
pubmed: 32796099
Br J Ophthalmol. 2015 Nov;99(11):1531-5
pubmed: 25953846
Br J Ophthalmol. 1998 Jul;82(7):773-9
pubmed: 9924370
Eur Thyroid J. 2016 Mar;5(1):9-26
pubmed: 27099835
Clin Endocrinol (Oxf). 2008 Dec;69(6):943-50
pubmed: 18429949
Eye (Lond). 2020 Sep;34(9):1662-1671
pubmed: 31836832
J Clin Pharm Ther. 2000 Jun;25(3):227-34
pubmed: 10886467
J Clin Endocrinol Metab. 2013 Apr;98(4):1443-9
pubmed: 23408569
Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):273-9
pubmed: 22632364
Thyroid. 2014 Sep;24(9):1407-18
pubmed: 24967886
Orphanet J Rare Dis. 2017 Apr 20;12(1):72
pubmed: 28427469
Int Ophthalmol. 2014 Feb;34(1):1-6
pubmed: 23549634
Intern Med. 2014;53(5):353-60
pubmed: 24583420
J Clin Endocrinol Metab. 2012 Jul;97(7):2325-32
pubmed: 22518849

Auteurs

Soma Farag (S)

Imperial College School of Medicine, Imperial College London, London, United Kingdom.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.

Claire Feeney (C)

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
Department of Ophthalmology, The Western Eye Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.

Vickie Lee (V)

Department of Ophthalmology, The Western Eye Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
Department of Ophthalmology, Central Middlesex Hospital, London North West Healthcare NHS Trust, London, United Kingdom.

Sonali Nagendran (S)

Department of Ophthalmology, Central Middlesex Hospital, London North West Healthcare NHS Trust, London, United Kingdom.

Rajni Jain (R)

Department of Ophthalmology, The Western Eye Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.

Ahmad Aziz (A)

Department of Ophthalmology, The Western Eye Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
Department of Ophthalmology, Central Middlesex Hospital, London North West Healthcare NHS Trust, London, United Kingdom.

Rashmi Akishar (R)

Department of Ophthalmology, The Western Eye Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.

Vassiliki Bravis (V)

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.

Karim Meeran (K)

Imperial College School of Medicine, Imperial College London, London, United Kingdom.
Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH